HARESH THARWANI: Open Payments
NPI 1790869618 · CARY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$52,583 in 283 payments from 20 companies in 2025. Trend: 2023 $21,541 · 2024 $33,102 · 2025 $52,583
Speaker / faculty: $36,910Food & beverage: $5,923Consulting: $5,390Travel & lodging: $4,269Education: $90
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 43 | $29,308 |
| ABBVIE INC. | 91 | $19,538 |
| LivaNova USA, Inc. | 11 | $865 |
| Teva Pharmaceuticals USA, Inc. | 27 | $666 |
| Neurocrine BioSciences, Inc. | 21 | $433 |
| Alkermes, Inc. | 11 | $331 |
| Vanda Pharmaceuticals Inc. | 14 | $278 |
| E.R. Squibb & Sons, L.L.C. | 16 | $270 |
| Janssen Pharmaceuticals, Inc | 12 | $204 |
| Lundbeck LLC | 4 | $202 |
Products named: CAPLYTA, VRAYLAR, VNS THERAPY SYMMETRY MODEL 8103 GENERATOR, INGREZZA, UZEDY, COBENFY, REXULTI, AUSTEDO XR.
Industry payments across NC — which companies pay providers there.
